The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmacology
Reference58 articles.
1. Cancer invasion and the microenvironment: plasticity and reciprocity;Friedl;Cell,2011
2. Nanoparticle and targeted systems for cancer therapy;Brannon-Peppas;Adv. Drug Deliv. Rev.,2004
3. Nanoparticle therapeutics: an emerging treatment modality for cancer;Davis;Nat. Rev. Drug Discov.,2008
4. Macromolecular therapeutics in cancer treatment: the epr effect and beyond;Maeda;J. Control. Release,2012
5. Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a japan clinical oncology group study (jcog9401);Shien;Int. J. Clin. Oncol.,2014
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Injectable Hydrogels for Intratumoral Administration Against Breast Cancer;Journal of Polymers and the Environment;2024-07-09
2. Ultrasound-powered hydrogen peroxide-responsive Janus micromotors for targeted thrombolysis and recurrence inhibition;Chemical Engineering Journal;2024-03
3. Programmed Co-delivery of tamoxifen and docetaxel using lipid-coated mesoporous silica nanoparticles for overcoming CYP3A4-mediated resistance in triple-negative breast cancer treatment;Biomedicine & Pharmacotherapy;2024-01
4. Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy;European Journal of Medicinal Chemistry;2023-10
5. Revolutionizing anticancer drug delivery: Exploring the potential of tamoxifen-loaded nanoformulations;Journal of Drug Delivery Science and Technology;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3